Therapeutic interventions for users of amphetamine-type stimulants (ATS)

The interventions described in this brief adhere to internationally accepted principles of drug treatment, are evidence based and reflect a public health perspective.  These are alternatives proposed to the predominantly law-enforcement approaches to ATS use currently common in the Asia–Pacific region. Medical interventions for the treatment of physical and mental health problems are described, as well as psychosocial treatment approaches including community-based interventions.

Download

Harm reduction and brief interventions for ATS users

This brief outlines public health interventions directed at those who use amphetamine-type stimulants (ATS). Research indicates that the majority of ATS users are casual/experimental users who do not require intensive treatment interventions. Instead, they require information and counselling to enable them to appreciate the potential risks from ATS use and take measures to mitigate these harms.

Download

WHO : Patterns and consequences of the use of amphetamine-type stimulants (ATS)

This technical brief reviews the patterns and consequences of psychostimulant  use. The physiological, medical and psychological consequences of low- or  high-dose as well as short- or long-term amphetamine use are described.  Amphetamine dependence and the risks for HIV and hepatitis infections are  also described.

Download

New report on synthetic drugs trend in Asia

26 November 2009 -  East and South-East Asia face an increasing challenge in synthetic drugs, particularly amphetamine-type stimulants, due to their availability and adaptability to rapidly shifting markets.

While countries in the region have increased their efforts to tackle the problem, a new UNODC report highlights the continued need for joint efforts, both at the national and regional levels.

Read the rest of this entry »